Gallwitz, B. (2018). The Cardiovascular Benefits Associated with the Use of Sodium-Glucose Cotransporter 2 Inhibitors – Real-World Data. Eur Endocrinol.
Παραπομπή Chicago StyleGallwitz, Baptist. "The Cardiovascular Benefits Associated With the Use of Sodium-Glucose Cotransporter 2 Inhibitors – Real-World Data." Eur Endocrinol 2018.
Παραπομπή MLAGallwitz, Baptist. "The Cardiovascular Benefits Associated With the Use of Sodium-Glucose Cotransporter 2 Inhibitors – Real-World Data." Eur Endocrinol 2018.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.